The stock price of Teleflex (NYSE:TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a decline of 12% over the last month, while it was down ...

Teleflex shares fell after the medical technology company said it was parting ways with its chief executive officer, and cut its outlook for the year. The stock was down 13% to $110.36 in late morning ...

Teleflex announced a major leadership transition effective January 7–8, 2026, with long-time Chairman, President and CEO Liam Kelly departing and board member Stuart Randle, a veteran medical device ...

We believe F5 stock (NASDAQ: FFIV), an application security and cloud networking company, and Teleflex stock (NYSE: TFX), best known for its single-use medical products for common diagnostic and ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...

The latest price target for Teleflex (NYSE:TFX) was reported by Truist Securities on May 5, 2025. The analyst firm set a price target for $137.00 expecting TFX to rise to within 12 months (a possible ...

Shares of Teleflex Inc. TFX rallied 2.55% to $112.81 Friday, on what proved to be an all-around positive trading session for ...

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported ...